Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.

NCT06863467 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency, Chronic
Chronic Kidney Disease stage3
Chronic Kidney Disease stage4

Interventions

DRUG: Intravenous Gemini
DRUG: Intravenous placebo

Sponsor

Revelation Biosciences, Inc